PMID: 8955307Dec 1, 1996Paper

PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance

Journal of Bacteriology
J S Gunn, S I Miller

Abstract

Antimicrobial cationic peptides are a host defense mechanism of many animal species including mammals, insects, and amphibians. Salmonella typhimurium is an enteric and intracellular pathogen that interacts with antimicrobial peptides within neutrophil and macrophage phagosomes and at intestinal mucosal surfaces. The Salmonella spp. virulence regulators, PhoP and PhoQ, activate the transcription of genes (pag) within macrophage phagosomes necessary for resistance to cationic antimicrobial peptides. One PhoP-activated gene, pagB, forms an operon with pmrAB (5' pagB-pmrA-pmrB 3'), a two-component regulatory system involved in resistance to the antimicrobial peptides polymyxin, azurocidin (CAP37), bactericidal/permeability-increasing protein (BPI or CAP57), protamine, and polylysine. Expression of pmrAB increased transcription of pagB-pmrAB by activation of a promoter 5' to pagB. pmrAB is also expressed from a second promoter, not regulated by PhoP-PhoQ or PmrA-PmrB, located within the pagB coding sequence. S. typhimurium strains with increased pag locus expression were demonstrated to be polymyxin resistant because of induction of pagB-pmrAB; however, PmrA-PmrB was not responsible for the increased sensitivity of PhoP-null mutant...Continue Reading

References

Jan 1, 1977·Annual Review of Biochemistry·D R StormP E Swanson
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Sep 1, 1992·Microbiological Reviews·M Vaara
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C M Alpuche ArandaS I Miller
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·E A GroismanF Heffron
Aug 1, 1992·The Journal of Cell Biology·M E SelstedA J Ouellette
Nov 1, 1990·The Journal of Clinical Investigation·J K Spitznagel
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S I MillerJ J Mekalanos
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·E A GroismanF Heffron
Oct 1, 1985·The Journal of Clinical Investigation·T GanzR I Lehrer
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P I FieldsF Heffron
Apr 1, 1983·Journal of Bacteriology·S MichaelisJ Beckwith
Aug 1, 1995·Journal of Bacteriology·F C SonciniE A Groisman
Sep 1, 1995·Journal of Bacteriology·J S GunnS I Miller
Jul 1, 1993·Journal of Bacteriology·I Behlau, S I Miller

❮ Previous
Next ❯

Citations

Jun 30, 2000·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D G MarshallC J Dorman
Nov 4, 2000·Expert Opinion on Investigational Drugs·M J Macielag, R Goldschmidt
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bärbel RaupachStefan H E Kaufmann
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Alexander M Cole, Alan J Waring
May 18, 2006·The Journal of Biological Chemistry·C Michael ReynoldsM Stephen Trent
Mar 21, 2009·PLoS Genetics·J Christian PerezEduardo A Groisman
Dec 27, 2011·Gut Microbes·Sandrine Tchaptchet, Jonathan Hansen
Jun 27, 2013·Annual Review of Microbiology·H Deborah Chen, Eduardo A Groisman
Dec 17, 2014·Frontiers in Microbiology·Abiola O OlaitanJean-Marc Rolain
Jan 22, 2015·Antimicrobial Agents and Chemotherapy·Erica J RubinM Stephen Trent
May 1, 2015·Antibiotics·Victor I Band, David S Weiss
Nov 19, 2015·Proceedings of the National Academy of Sciences of the United States of America·Enrique LlobetJosé A Bengoechea
May 30, 2016·Annals of Saudi Medicine·Gul R YilmazMehmet A Tasyaran
Jun 12, 2019·Journal of Bacteriology·Alexander D PalmerJames M Slauch
Jun 11, 1998·Molecular Microbiology·R L Smith, M E Maguire
Mar 17, 2001·Molecular Microbiology·C R JohnsonJ J McFadden
Mar 21, 1998·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·E A Groisman
Dec 3, 1999·Immunological Reviews·J C SirardJ P Kraehenbuhl
Feb 1, 2005·FEMS Immunology and Medical Microbiology·Rita TamayoJohn S Gunn
Mar 31, 2004·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·M Stephen Trent
Feb 7, 2008·Expert Review of Anti-infective Therapy·Arvind K Bansal
Sep 5, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Marta Biedzka-Sarek, Mika El Skurnik
Jan 23, 2014·Proceedings of the National Academy of Sciences of the United States of America·Zachary D DalebrouxSamuel I Miller
Oct 8, 2013·Applied and Environmental Microbiology·Bianca AudrainJean-Marc Ghigo
Nov 28, 2014·The Journal of Antimicrobial Chemotherapy·Nicolas KiefferMarisa Haenni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.